MedPath

Inhalation Sciences Sweden AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Explorative Clinical Investigation to Investigate the Ability of PreciseInhale to Direct Regional Lung Targeting and Reduce the Degree of Throat Deposition and Subsequent Gastrointestinal Absorption in Healthy Volunteers After Inhalation of Test Drug Substances Via the PreciseInhale System

Not Applicable
Completed
Conditions
Nebulizers and Vaporizers
First Posted Date
2021-07-01
Last Posted Date
2022-04-11
Lead Sponsor
Inhalation Sciences Sweden AB
Target Recruit Count
12
Registration Number
NCT04946630
Locations
🇸🇪

Clinical Trial Consultants AB, Uppsala, Sweden

News

Inhalation Sciences Secures Recurring Orders from Global Pharma Customer, Strengthening Preclinical Research Platform

Inhalation Sciences Sweden AB received two significant orders totaling EUR 55,250 from a recurring global pharmaceutical customer, demonstrating strong validation of their PreciseInhale® research platform.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.